Property:Sequencing platform
From BugSigDB
This is a property of type Text.
Manufacturer and experimental platform used for quantifying microbial abundance (en)
Allowed values[edit source]
- DNA-DNA Hybridization
- Human Intestinal Tract Chip
- Illumina
- Ion Torrent
- Mass spectrometry
- Non-quantitative PCR
- PacBio RS
- PhyloChip
- Roche454
- RT-qPCR
- Sanger
- Nanopore
- BGISEQ-500 Sequencing
- DNBSEQ-T7
- MGISEQ-2000
- HTF-Microbi.Array
E
Evaluation of superinfection, antimicrobial usage, and airway microbiome with metagenomic sequencing in COVID-19 patients: A cohort study in Shanghai/Experiment 2 +
BGISEQ-500 Sequencing +
Evaluation of superinfection, antimicrobial usage, and airway microbiome with metagenomic sequencing in COVID-19 patients: A cohort study in Shanghai/Experiment 1 +
BGISEQ-500 Sequencing +
G
Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma/Experiment 1 +
BGISEQ-500 Sequencing +
C
Cross-Sectional Study on the Gut Microbiome of Parkinson's Disease Patients in Central China/Experiment 1 +
BGISEQ-500 Sequencing +
M
Metagenomic sequencing reveals altered gut microbial compositions and gene functions in patients with non-segmental vitiligo/Experiment 1 +
BGISEQ-500 Sequencing +
T
Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice/Experiment 1 +
BGISEQ-500 Sequencing +
The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects/Experiment 1 +
DNA-DNA Hybridization +
C
Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients/Experiment 2 +
DNBSEQ-T7 +
Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients/Experiment 1 +
DNBSEQ-T7 +
M
Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy/Experiment 1 +
DNBSEQ-T7 +
S
Stachyose ameliorates obesity-related metabolic syndrome via improving intestinal barrier function and remodeling gut microbiota/Experiment 1 +
DNBSEQ-T7 +
I
IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation/Experiment 1 +
HTF-Microbi.Array +
IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation/Experiment 2 +
HTF-Microbi.Array +
IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation/Experiment 3 +
HTF-Microbi.Array +
IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation/Experiment 4 +
HTF-Microbi.Array +
H
Human intestinal microbiota composition is associated with local and systemic inflammation in obesity/Experiment 3 +
Human Intestinal Tract Chip +
Human intestinal microbiota composition is associated with local and systemic inflammation in obesity/Experiment 2 +
Human Intestinal Tract Chip +
Human intestinal microbiota composition is associated with local and systemic inflammation in obesity/Experiment 4 +
Human Intestinal Tract Chip +
Human intestinal microbiota composition is associated with local and systemic inflammation in obesity/Experiment 1 +
Human Intestinal Tract Chip +
M
Showing 1 related entity.
{ "type": "PROPERTY_CONSTRAINT_SCHEMA", "constraints": { "type_constraint": "_txt", "allowed_values": [ "DNA-DNA Hybridization", "Human Intestinal Tract Chip", "Illumina", "Ion Torrent", "Non-quantitative PCR", "PacBio RS", "PhyloChip", "Roche454", "RT-qPCR", "Mass spectrometry", "Nanopore", "BGISEQ-500 Sequencing", "DNBSEQ-T7", "MGISEQ-2000", "HTF-Microbi.Array", "Sanger" ] } }